Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Patients requiring a permanent pacemaker after TAVR face higher long-term risk of death
As TAVR continues to grow in popularity, researchers noted, it becomes more and more important to know how different complications impact long-term outcomes.
CMS proposes Medicare coverage for T-TEER
CMS has proposed covering tricuspid TEER for patients who present with symptomatic tricuspid regurgitation despite optimal medical therapy. The agency still has questions about the available data, however, and is seeking public comments as it makes its final decision.
Quality of care for heart patients does not improve in first year of ACO participation
Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.
Routine interventional procedure may present new endometriosis treatment option
Known to be extremely painful at times, many women with endometriosis consider flare-ups of the condition to be debilitating.
Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology
Boston Scientific hopes to officially launch its new IVL system in the first half of 2026.

The DurAVR TAVR system from Anteris Technologies

New-look TAVR valve shows early promise in patients with severe AS

One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.

ChatGPT passes interventional cardiology certification exam

The popular AI chatbot's performance highlighted both its strengths and its weaknesses. It can answer multiple-choice questions, for example, but it struggles with consistency.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock

TAVR is also associated with a lower risk of acute kidney injury in this patient population. In-hospital mortality rates, however, are similar between the two treatment options.

When Apple previewed its watchOS 9 update in early June, one of the key features the company highlighted was a new tracking option for atrial fibrillation (AFib) patients. The AFib History feature, approved for patients 22 years and older who have been diagnosed with AFib, was designed to help users gain a better understanding of their symptoms and easily share data with healthcare providers.

Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices

Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients.

MRI sensor made from fiber optic cables detects errors in magnetic field at lighting fast speed

New sensor detects errors in MRI exams at 'lightning fast' speed

The sensor uses laser light encased in fiber cables and a small glass container filled with gas to measure changes in the strength of a magnetic field.

First-in-Man Experience of Robotic-Assisted Transcatheter Edge-to-Edge Repair With Pure Echo Guidance

Cardiologists and surgeons perform world’s first robot-assisted TEER

A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.

Sunil Rao, MD, NYU, explains the DANGER-SHOCK trial at ACC 2024 and how it may help improve cardiogenic shock survival.

Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials

Sunil Rao, MD, director of interventional cardiology at NYU Langone, says DanGer Shock is a "very, very important study" when it comes to the treatment of cardiogenic shock.

Clinical

Patients requiring a permanent pacemaker after TAVR face higher long-term risk of death

CMS proposes Medicare coverage for T-TEER

Quality of care for heart patients does not improve in first year of ACO participation

Routine interventional procedure may present new endometriosis treatment option

Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology